What is Cushing's syndrome? Cushing's syndrome is a hormonal disorder. It’s caused when you have high levels of the hormone cortisol over a long time. Cushing's syndrome is fairly rare. It most often ...

Eculizumab effectively reduced MG-ADL scores and corticosteroid use in thymoma-associated myasthenia gravis patients by week 12. The monoclonal antibody targets complement protein C5, preventing ...

Muhammad Haroon, being a Specialist Registrar, is seeking a dual accreditation in Rheumatology and General Medicine. He is a graduate of King Edward Medical College Lahore, Pakistan and did his ...

Paraneoplastic neurologic syndromes (PNSs) are remote effects of cancer with an immune-mediated pathogenesis ... and anti-Tr (associated with Hodgkin lymphoma) and anti-CRMP-5 (associated with ...

Ravulizumab had an early and sustained clinical effect which contributed to the avoidance of intubation. A patient with thymoma-associated myasthenia gravis (MG) was successfully treated with ...

CBX-12 is under clinical development by Cybrexa and currently in Phase II for Thymoma (Thymic Epithelial Tumor). According to GlobalData, Phase II drugs for Thymoma (Thymic Epithelial Tumor) does not ...